E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -17.73% -47.96% -34.57% -56.58% 110.06%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -21.81% -46.52% -38.45% -65.75% -14.51%
Operating Income 21.81% 46.52% 38.45% 65.75% 14.51%
Income Before Tax 17.28% 96.81% 38.43% -156.98% 21.39%
Income Tax Expenses -- 100.12% -- 20.00% --
Earnings from Continuing Operations 17.27% 96.48% 20.24% -185.18% 21.40%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 17.27% 96.48% 20.24% -185.18% 21.40%
EBIT 21.81% 46.52% 38.45% 65.75% 14.51%
EBITDA 21.80% 46.55% 38.47% 65.78% 14.52%
EPS Basic 91.95% 99.80% 96.66% -102,380.79% 84.42%
Normalized Basic EPS 91.86% 96.73% 97.42% -13,313.78% 44.18%
EPS Diluted 91.95% 99.80% 96.66% -102,380.79% 84.42%
Normalized Diluted EPS 91.86% 96.73% 97.42% -13,313.78% 44.18%
Average Basic Shares Outstanding 915.83% 1,537.06% 2,289.27% -99.76% 41.01%
Average Diluted Shares Outstanding 915.83% 1,537.06% 2,289.27% -99.76% 41.01%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings